{"id":7385,"date":"2015-11-25T10:53:17","date_gmt":"2015-11-25T08:53:17","guid":{"rendered":"https:\/\/faus-moliner.com\/?p=7385"},"modified":"2016-02-18T12:13:46","modified_gmt":"2016-02-18T10:13:46","slug":"the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2","status":"publish","type":"post","link":"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/","title":{"rendered":"Consultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel"},"content":{"rendered":"

Background<\/strong><\/p>\n

Community competition law, as is well known, considers that agreements between companies, decisions by business associations and concerted practices that could potentially affect trade between Member States and that may prevent, restrict or distort competition in the internal market are inconsistent with said market and thus prohibits them. The Spanish Competition Law contains similar provisions.<\/p>\n

When persecuting prohibited practices, the authorities tasked with ensuring compliance with these rules take a particularly aggressive stance when it comes to cartels, agreements between competitors that serve for market-sharing, to set prices or for similar practices. Normally, as part of a cartel, commercially sensitive information is exchanged between competitors. The judgment in question represents an excellent opportunity to go over the doctrine with respect to the liability that may be incurred by those offering services to companies that participate in cartels, aiding and partaking in their management.<\/p>\n

Active participation<\/strong><\/p>\n

According to European case law, companies that contribute to the common objectives pursued by the participants in the cartel, when aware of said objectives or capable of having foreseen them, may be deemed guilty of an offence and fined as a result. For this purpose, it is irrelevant that the company in question is a consultancy firm that does not compete in the same market as the participants in the cartel.<\/p>\n

The case in hand serves to reaffirm this concept, originally addressed by the Commission in 1980; in this instance, the fined consultancy firm had played an essential role in the cartel by: organising meetings between those involved; actively participating in said meetings; gathering and communicating sales data without aggregating data; proposing its involvement as a moderator in the event of any disputes; and encouraging those involved to reach agreements. Accomplices of such an offence, as a result, may be accused of violating competition rules and be subject to a fine as a result.<\/p>\n

Passive participation<\/strong><\/p>\n

The judgment also states that anybody attending a meeting at which agreements of an anti-competitive nature are discussed or signed must expressly object to such agreements and leave the meeting having made his\/her opinion clear. Otherwise, his\/her complicity may result in legal liability, as the tacit approval of an unlawful initiative without publicly distancing oneself from its content or reporting it to the administrative authorities is considered as tantamount to encouraging the corresponding parties to proceed with the infringement and hinders its detection.<\/p>\n","protected":false},"excerpt":{"rendered":"

Background Community competition law, as is well known, considers that agreements between companies, decisions by business associations and concerted practices that could potentially affect trade between Member States and that may prevent, restrict or distort competition in the internal market are inconsistent with said market and thus prohibits them. The Spanish Competition Law contains similar… <\/p>\n

<\/div>\n

Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[72,76,227],"tags":[],"coauthors":[105],"class_list":["post-7385","post","type-post","status-publish","format-standard","hentry","category-capsulas-en","category-competition-law","category-competition-law-2"],"acf":[],"yoast_head":"\nConsultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel - Faus Moliner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Consultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel - Faus Moliner\" \/>\n<meta property=\"og:description\" content=\"Background Community competition law, as is well known, considers that agreements between companies, decisions by business associations and concerted practices that could potentially affect trade between Member States and that may prevent, restrict or distort competition in the internal market are inconsistent with said market and thus prohibits them. The Spanish Competition Law contains similar... Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Faus Moliner\" \/>\n<meta property=\"article:published_time\" content=\"2015-11-25T08:53:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-02-18T10:13:46+00:00\" \/>\n<meta name=\"author\" content=\"Jordi Faus\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jordi Faus\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/\"},\"author\":{\"name\":\"Jordi Faus\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\"},\"headline\":\"Consultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel\",\"datePublished\":\"2015-11-25T08:53:17+00:00\",\"dateModified\":\"2016-02-18T10:13:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/\"},\"wordCount\":414,\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"articleSection\":[\"Capsulas\",\"Competition Law\",\"Competition Law\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/\",\"url\":\"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/\",\"name\":\"Consultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel - Faus Moliner\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\"},\"datePublished\":\"2015-11-25T08:53:17+00:00\",\"dateModified\":\"2016-02-18T10:13:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/faus-moliner.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Consultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"name\":\"faus-moliner.com\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/faus-moliner.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\",\"name\":\"Faus Moliner\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"contentUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"width\":400,\"height\":283,\"caption\":\"Faus Moliner\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/2372042\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\",\"name\":\"Jordi Faus\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"caption\":\"Jordi Faus\"},\"description\":\"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.\",\"sameAs\":[\"https:\/\/faus-moliner.com\/\"],\"url\":\"https:\/\/faus-moliner.com\/en\/author\/jordi-faus\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Consultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel - Faus Moliner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/","og_locale":"en_US","og_type":"article","og_title":"Consultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel - Faus Moliner","og_description":"Background Community competition law, as is well known, considers that agreements between companies, decisions by business associations and concerted practices that could potentially affect trade between Member States and that may prevent, restrict or distort competition in the internal market are inconsistent with said market and thus prohibits them. The Spanish Competition Law contains similar... Read More","og_url":"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/","og_site_name":"Faus Moliner","article_published_time":"2015-11-25T08:53:17+00:00","article_modified_time":"2016-02-18T10:13:46+00:00","author":"Jordi Faus","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jordi Faus","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/#article","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/"},"author":{"name":"Jordi Faus","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260"},"headline":"Consultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel","datePublished":"2015-11-25T08:53:17+00:00","dateModified":"2016-02-18T10:13:46+00:00","mainEntityOfPage":{"@id":"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/"},"wordCount":414,"publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"articleSection":["Capsulas","Competition Law","Competition Law"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/","url":"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/","name":"Consultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel - Faus Moliner","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/#website"},"datePublished":"2015-11-25T08:53:17+00:00","dateModified":"2016-02-18T10:13:46+00:00","breadcrumb":{"@id":"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/faus-moliner.com\/en\/the-price-of-medicinal-products-in-europe-cannot-be-used-to-reduce-their-prices-in-spain-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/faus-moliner.com\/en\/"},{"@type":"ListItem","position":2,"name":"Consultancy firms may be fined for restricting competition if they actively collaborate in the management of a cartel"}]},{"@type":"WebSite","@id":"https:\/\/faus-moliner.com\/en\/#website","url":"https:\/\/faus-moliner.com\/en\/","name":"faus-moliner.com","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/faus-moliner.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/faus-moliner.com\/en\/#organization","name":"Faus Moliner","url":"https:\/\/faus-moliner.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","width":400,"height":283,"caption":"Faus Moliner"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/2372042\/admin\/"]},{"@type":"Person","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260","name":"Jordi Faus","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5","url":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","caption":"Jordi Faus"},"description":"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.","sameAs":["https:\/\/faus-moliner.com\/"],"url":"https:\/\/faus-moliner.com\/en\/author\/jordi-faus\/"}]}},"_links":{"self":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/7385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/comments?post=7385"}],"version-history":[{"count":0,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/7385\/revisions"}],"wp:attachment":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/media?parent=7385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/categories?post=7385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/tags?post=7385"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/coauthors?post=7385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}